作为瘤原生生物标志物,NABP2促进肝细胞癌的进展和转移
Hong Peng1, Shenglan Cai2,3,4, Ruochan Chen3,4
1Medical School, Huanghe Science & Technology College Zhengzhou, Henan, China.
American journal of translational research
|July 12, 2023
概括
核酸结合蛋白2 (NABP2) 在肝细胞癌 (HCC) 中升高,表明预后不佳. 针对NABP2并使用基于NABP2的风险特征可能会改善HCC患者的治疗结果和治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战.
- 了解HCC病变的新型分子参与者对于开发有效疗法至关重要.
研究的目的:
- 研究核酸结合蛋白2 (NABP2) 在HCC中的作用和生物功能.
- 评估NABP2作为预后生物标志物和HCC的治疗点.
主要方法:
- 对HCC数据集进行全面的生物信息学分析.
- 使用HCC细胞系进行功能实验.
- 预后价值评估,免疫细胞透分析和药物敏感性预测.
主要成果:
- 在HCC中,NABP2表达显著上调,与更差的预后和更短的存活时间相关.
- NABP2作为一个独立的预后因素,与癌症途径和免疫失调有关.
- 在NABP2 Knockdown中,它可以抑制HCC细胞的增殖和迁移,同时促进细胞亡.
- 与NABP2相关的风险标志有效预测患者的预后,并识别潜在的治疗药物.
结论:
- NABP2作为一个有价值的预后生物标志物和HCC的潜在治疗点.
- 基于NABP2的风险签名可以帮助临床医生预测HCC患者的预后,并指导治疗决策.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


